"Tough economic times cause marketers to be held more accountable for spending and measurement," said Mark Bard, Manhattan Research President, "With over 145 million consumers online for health, new media offers cost-effective ways to reach and engage target audiences. In order to efficiently allocate budgets, companies must understand the rapidly evolving health media channels and how consumers are using them to complement and replace the traditional offline health system."
Manhattan Research will host a webinar event, "Is TV Dead? How the New New Media Changes Pharmaceutical DTC Advertising," on October 14th at 11am EST and October 16th at 3pm EST. The webinar will help pharmaceutical and healthcare marketers understand the optimal media mix in the face of an uncertain economy. Meredith Abreu Ressi, VP of Research, will overview key market data and trends from CybercitizenÃ Health v8.0. Register here: https://manhattanresearch.webex.com.
- Evolving Consumer Use of TV and Video
How can marketers play the consumer shift to online video for entertainment and information to their advantage?
- Going Mobile for Health
What are the latest trends and strategies for reaching a growing market of consumers using their mobile phones to find health info?
- Engaging in Health 2.0
How are patients and caregivers using online communities, widgets, blogs, and wikis, and what should companies and agencies be doing about it? This topic is especially relevant for marketers looking to reach those most active in health social media, like cancer and fibromyalgia patients.
- The Online Health Shake Up
What will the recent Waterfront Media-Revolution Health merger mean for pharma companies and their media partners? How can marketers stay ahead of the curve? Will sites eventually serve as a conduit linking physicians with their patients?
- The Doctorâ¦errâ¦the Internet will See You Now
How does the decrease in consumer reliance on the physician affect your brand?
About Cybercitizen® Health v8.0
Cybercitizen® Health was fielded in Q3 2008 among 8,714 U.S. adults (ages 18+). In addition to the data, clients receive strategic deliverables including research reports, client briefings, and access to the Manhattan Research analyst team to answer specific questions. For topics and available therapeutic segmentations (80+), visit http://www.manhattanresearch.com/cch.
About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.